# Selective oxidative stress induces dual damage to telomeres and mitochondria in human T cells

**Authors:** Ling Wang, Zeyuan Lu, Juan Zhao, Madison Schank, Dechao Cao, Xindi Dang, Lam Nhat Nguyen, Lam Ngoc Thao Nguyen, Sushant Khanal, Jinyu Zhang, Xiao Y. Wu, Mohamed El Gazzar, Shunbin Ning, Jonathan P. Moorman, Zhi Q. Yao

PMC · DOI: 10.1111/acel.13513 · 2021-11-09

## TL;DR

Oxidative stress causes damage to both telomeres and mitochondria in T cells, leading to cell death, and this happens through a connection between these two parts of the cell.

## Contribution

A new chemoptogenetic tool was used to show that oxidative stress at either telomeres or mitochondria causes damage to both.

## Key findings

- Targeted oxidative stress at telomeres causes mitochondrial dysfunction and cell death.
- Oxidative stress at mitochondria also damages telomeres and leads to apoptosis.
- Blocking ROS formation reverses damage to telomeres and mitochondria.

## Abstract

Oxidative stress caused by excess reactive oxygen species (ROS) accelerates telomere erosion and mitochondrial injury, leading to impaired cellular functions and cell death. Whether oxidative stress‐mediated telomere erosion induces mitochondrial injury, or vice versa, in human T cells—the major effectors of host adaptive immunity against infection and malignancy—is poorly understood due to the pleiotropic effects of ROS. Here we employed a novel chemoptogenetic tool that selectively produces a single oxygen (1O2) only at telomeres or mitochondria in Jurkat T cells. We found that targeted 1O2 production at telomeres triggered not only telomeric DNA damage but also mitochondrial dysfunction, resulting in T cell apoptotic death. Conversely, targeted 1O2 formation at mitochondria induced not only mitochondrial injury but also telomeric DNA damage, leading to cellular crisis and apoptosis. Targeted oxidative stress at either telomeres or mitochondria increased ROS production, whereas blocking ROS formation during oxidative stress reversed the telomeric injury, mitochondrial dysfunction, and cellular apoptosis. Notably, the X‐ray repair cross‐complementing protein 1 (XRCC1) in the base excision repair (BER) pathway and multiple mitochondrial proteins in other cellular pathways were dysregulated by the targeted oxidative stress. By confining singlet 1O2 formation to a single organelle, this study suggests that oxidative stress induces dual injury in T cells via crosstalk between telomeres and mitochondria. Further identification of these oxidation pathways may offer a novel approach to preserve mitochondrial functions, protect telomere integrity, and maintain T cell survival, which can be exploited to combat various immune aging‐associated diseases.

Oxidative stress caused by excess reactive oxygen species (ROS) accelerates telomere erosion and mitochondrial injury, leading to impaired cellular functions and cell death. By selectively producing singlet 1O2 to a single organelle, Wang and Lu et al. demonstrate that oxidative stress induces dual injury in T cells via crosstalk between telomeres and mitochondria, and also explore potential molecules and pathways that promote this dual‐damage.

## Linked entities

- **Genes:** XRCC1 (X-ray repair cross complementing 1) [NCBI Gene 7515]
- **Proteins:** XRCC1 (X-ray repair cross complementing 1)

## Full-text entities

- **Genes:** CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, RPA1 (replication protein A1) [NCBI Gene 6117] {aka HSSB, MST075, PFBMFT6, REPA1, RF-A, RP-A}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, COX17 (cytochrome c oxidase copper chaperone COX17) [NCBI Gene 10063], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, XRCC1 (X-ray repair cross complementing 1) [NCBI Gene 7515] {aka RCC, SCAR26}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, PPARGC1B (PPARG coactivator 1 beta) [NCBI Gene 133522] {aka ERRL1, PERC, PGC-1(beta), PGC1B}, TTC19 (tetratricopeptide repeat domain 19) [NCBI Gene 54902] {aka 2010204O13Rik, MC3DN2}, TERF2 (telomeric repeat binding factor 2) [NCBI Gene 7014] {aka TRBF2, TRF2}, TERF1 (telomeric repeat binding factor 1) [NCBI Gene 7013] {aka PIN2, TRBF1, TRF, TRF1, hTRF1-AS, t-TRF1}, COX4I1 (cytochrome c oxidase subunit 4I1) [NCBI Gene 1327] {aka COX IV-1, COX4, COX4-1, COXIV, COXIV-1, MC4DN16}, GADD45A (growth arrest and DNA damage inducible alpha) [NCBI Gene 1647] {aka DDIT1, GADD45}, GRB2 (growth factor receptor bound protein 2) [NCBI Gene 2885] {aka ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2}, H2AX (H2A.X variant histone) [NCBI Gene 3014] {aka H2A.X, H2A/X, H2AFX}, Terf1 (telomeric repeat binding factor 1) [NCBI Gene 21749] {aka Pin2, Trbf1, Trf1}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, NRF1 (nuclear respiratory factor 1) [NCBI Gene 4899] {aka ALPHA-PAL}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, ATP8A2 (ATPase phospholipid transporting 8A2) [NCBI Gene 51761] {aka ATP, ATPIB, CAMRQ4, IB, ML-1}, FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, AK2 (adenylate kinase 2) [NCBI Gene 204] {aka ADK2}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, HLA-G (major histocompatibility complex, class I, G) [NCBI Gene 3135] {aka MHC-G}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, LIG3 (DNA ligase 3) [NCBI Gene 3980] {aka LIG2, LIG3alpha, MTDPS20}, ESRRA (estrogen related receptor alpha) [NCBI Gene 2101] {aka ERR1, ERRa, ERRalpha, ESRL1, NR3B1}, OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968] {aka HMMH, HOGG1, MUTM, OGH1}
- **Diseases:** mitochondrial dual-injury (MESH:D009105), DNA damage (MESH:D004266), MG (OMIM:614156), cancer (MESH:D009369), viral infection (MESH:D014777), RA (MESH:D001172), mitochondrial compromise (MESH:D028361), infectious and inflammatory diseases (MESH:D003141), telomere damage (MESH:C536801), inflammation (MESH:D007249), leukemia (MESH:D007938), HIV (MESH:D015658), cardiovascular disease (MESH:D002318), mitochondria (MESH:C564971), age-related neurodegenerative diseases (MESH:D019636), mitochondrial dysregulation (MESH:D021081), infection (MESH:D007239), AIDS (MESH:D000163)
- **Species:** hepatitis C virus [taxon 11103], Human immunodeficiency virus (species) [taxon 12721], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** FAP-mCer3 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_A1DA), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), E6-1 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0367), Jurkat J1.1 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_R861), J1-1 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_8279), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), mCer3 — Mus musculus (Mouse), Hybridoma (CVCL_C6V6)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8672791/full.md

---
Source: https://tomesphere.com/paper/PMC8672791